Incidence of central venous catheter-related bloodstream infections before, during, and after the SARS-CoV-2 pandemic: a registry-based cohort study
Authors:
Open Access
- 9 December 2025
- journal article
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 14 (1) , 149
Abstract
While the SARS-CoV-2 pandemic generally was associated with more healthcare-associated infections (HAI) we found fewer central venous catheter (CVC)-related bloodstream infections (CRBSI) during the pandemic as compared to the time period before in patients mainly with haematological malignancies. Since data on post-pandemic HAI are scarce, we conducted an analysis focused on post-pandemic CRBSI. We hypothesised that the CRBSI incidence has increased again after the SARS-CoV-2 pandemic. For this cohort study, data were derived from a multicentre real-world registry on routine CVC surveillance in haematology and oncology departments in Germany. CRBSI that occurred after and during the pandemic, respectively, were compared with those before the pandemic. Endpoints were CRBSI incidences and rates. A total of 1474, 1079, and 692 CVC from the pre-pandemic, pandemic, and post-pandemic period, respectively, were analysed. CVC were mostly used in patients with haematological malignancies. Compared to the CRBSI incidence of the pre-pandemic and pandemic cohorts (3.9 and 1.9/1000 CVC days, respectively; p < 0.001), the CRBSI incidence of the post-pandemic cohort was similar to the incidence of the pre-pandemic cohort (3.3/1000 CVC days; p = 0.43). Likewise, the CRBSI rate declined during the pandemic (6.0% vs. 2.9%; p < 0.001) and increased afterwards to a level comparable to that from the pre-pandemic period (4.8%; p = 0.29). In multivariable analysis, the time periods before and after the pandemic were independent CRBSI risk factors. Our data provide some evidence that following a temporary decline of CRBSI during the SARS-CoV-2 pandemic, CRBSI now returned to that observed in the pre-pandemic era. The online version contains supplementary material available at 10.1186/s13756-025-01674-8.Keywords
This publication has 14 references indexed in Scilit:
- Increased incidence of blood culture contaminations during and after the COVID-19 pandemicInfection, 2025
- Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020–2024Annals of Hematology, 2025
- Impact of the COVID-19 pandemic on the incidence and the epidemiology of catheter-related bloodstream infection two years laterHeliyon, 2024
- Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic reviewInfection Prevention in Practice, 2023
- The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer centerAmerican Journal of Infection Control, 2023
- Healthcare-associated infections (HAIs) during the coronavirus disease 2019 (COVID-19) pandemic: A time-series analysisAntimicrobial Stewardship & Healthcare Epidemiology, 2023
- Central venous catheter‐related bloodstream infections in patients with haematological malignancies during the SARS‐CoV‐2 pandemicBritish Journal of Haematology, 2022
- Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Annals of Hematology, 2020
- Surveillance of catheter-related bloodstream infections in haemato-oncology patients: comparison of two definitionsJournal of Hospital Infection, 2020
- Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical OncologyAnnals of Oncology, 2014